Salvinorin A and derivatives: Protection from metabolism does not prolong short-term, whole-brain residence
- 30 September 2009
- journal article
- Published by Elsevier BV in Neuropharmacology
- Vol. 57 (4), 386-391
- https://doi.org/10.1016/j.neuropharm.2009.06.044
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Evaluation of the transport, in vitro metabolism and pharmacokinetics of Salvinorin A, a potent hallucinogenEuropean Journal of Pharmaceutics and Biopharmaceutics, 2009
- Natural Products as Tools for Neuroscience: Discovery and Development of Novel Agents to Treat Drug AbuseJournal of Natural Products, 2008
- Unconditioned Behavioral Effects of the Powerful κ-Opioid Hallucinogen Salvinorin A in Nonhuman Primates: Fast Onset and Entry into Cerebrospinal FluidThe Journal of pharmacology and experimental therapeutics, 2008
- Pharmacokinetics of the potent hallucinogen, salvinorin A in primates parallels the rapid onset and short duration of effects in humansNeuroImage, 2008
- Salvinorin A Analogs as Probes in Opioid PharmacologyChemical Reviews, 2008
- Standard protecting groups create potent and selective κ opioids: Salvinorin B alkoxymethyl ethersBioorganic & Medicinal Chemistry, 2008
- 2-Methoxymethyl-Salvinorin B Is a Potent κ Opioid Receptor Agonist with Longer Lasting Action in Vivo Than Salvinorin AThe Journal of pharmacology and experimental therapeutics, 2007
- Possible Pharmacotherapy of the Opioid κ Receptor Agonist for Drug DependenceAnnals of the New York Academy of Sciences, 2004
- Antidepressant-Like Effects of κ-Opioid Receptor Antagonists in the Forced Swim Test in RatsJournal of Pharmacology and Experimental Therapeutics, 2003
- Pharmacological Mechanisms of Opioid AnalgesicsClinical Neuropharmacology, 1993